SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026462
Filing Date
2024-08-13
Accepted
2024-08-13 17:08:49
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20240630_10q.htm   iXBRL 10-Q 777328
2 EXHIBIT 10.5 ex_712155.htm EX-10.5 43585
3 EXHIBIT 10.6 ex_712156.htm EX-10.6 39083
4 EXHIBIT 10.7 ex_712157.htm EX-10.7 46633
5 EXHIBIT 31.1 ex_711658.htm EX-31.1 13719
6 EXHIBIT 31.2 ex_711659.htm EX-31.2 13690
7 EXHIBIT 32.1 ex_711660.htm EX-32.1 5156
8 EXHIBIT 32.2 ex_711661.htm EX-32.2 5050
  Complete submission text file 0001437749-24-026462.txt   3676554

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240630.xsd EX-101.SCH 33662
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240630_def.xml EX-101.DEF 238010
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240630_lab.xml EX-101.LAB 202883
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240630_pre.xml EX-101.PRE 256215
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20240630_cal.xml EX-101.CAL 24353
59 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240630_10q_htm.xml XML 363774
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 241202856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)